Save
Email
Print
Share
RSSBrowse News Stories
21 to 30 of 304 stories
view headlines only
-
Lymphoma
Diseases and Conditions
Today's Healthcare
Colon Cancer
Wounds and Healing
Multiple Sclerosis Research
Blood Levels of Immune Protein Predict Risk in Hodgkin Disease
December 10, 2012 — Researchers found levels galectin-1, an immunity-related protein, could be the basis of a test and potentially a targeted treatment for Hodgkin ... > full story -
Novel Drug Therapy Targets Aggressive Form of Non-Hodgkin's Lymphoma
December 10, 2012 — Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called ... > full story -
Pathway Identified in Human Lymphoma Points Way to New Blood Cancer Treatments
November 21, 2012 — Research, shows for the first time that the "unfolded protein response" is active in patients with human lymphomas and mice genetically bred to develop lymphomas. Importantly, when the UPR is ... > full story -
Can the Addition of Radiolabeled Treatments Improve Outcomes in Advanced Metastatic Disease?
November 13, 2012 — Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the ... > full story -
Genome Sequencing of Burkitt Lymphoma Reveals Unique Mutation
November 12, 2012 — In the first broad genetic landscape mapped of a Burkitt lymphoma tumor, scientists identified 70 mutations, including several that had not previously been associated with cancer and a new one that ... > full story -
New Target for Lung Cancer Treatment Identified
November 1, 2012 — Investigators have discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer ... > full story -
Scientists Harness Immune System to Prevent Lymphoma Relapse
October 18, 2012 — Scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body's own immune system, after highly promising early laboratory ... > full story -
Development of Lymphoma Depends on Platelet Derived Growth Factor Receptor B, Mouse Model Shows
October 15, 2012 — Anaplastic large cell lymphoma (ALCL) is even less attractive in real life than it is on paper. It is a highly aggressive type of lymphoma that generally occurs in children and young adults and that ... > full story -
Researchers Solve Puzzle of B-Cell Lymphoma Development
September 23, 2012 — In germinal centers, immune cells learn to fight pathogens with high specificity. Researchers have now identified subpopulations of B cells at the germinal centers which express the proto-oncogene ... > full story -
Many Options, Good Outcomes, for Early-Stage Follicular Lymphoma
August 21, 2012 — A new study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and ... > full story
Search ScienceDaily
Number of stories in archives: 137,306
more 
